Long-Term Liabilities: The sum of all non-current liabilities.
Unicycive Therapeutics, Inc. (UNCY) had Long-Term Liabilities of $0.22M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-12.82M |
|
-- |
|
-- |
|
$8.44M |
|
$-8.44M |
|
$-4.39M |
|
$-12.82M |
|
$-12.82M |
|
$-12.82M |
|
$-12.82M |
|
$-12.82M |
|
$-12.82M |
|
$-8.44M |
|
$-8.21M |
|
23.91M |
|
23.91M |
|
$-0.54 |
|
$-0.54 |
|
| Balance Sheet Financials | |
$63.55M |
|
$0.05M |
|
$0.86M |
|
$64.41M |
|
$26.48M |
|
-- |
|
|
Long-Term Liabilities |
$0.22M |
$26.70M |
|
$37.70M |
|
$37.70M |
|
$37.70M |
|
25.24M |
|
| Cash Flow Statement Financials | |
$-6.24M |
|
$-5.16M |
|
$19.57M |
|
$29.20M |
|
$37.37M |
|
$8.17M |
|
$0.75M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.40 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.25M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-34.01% |
|
-34.01% |
|
-19.91% |
|
-34.01% |
|
$1.49 |
|
$-0.26 |
|
$-0.26 |
|